Schluep M - Search Results

1

Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal study.

Jilek S, Jaquiéry E, Hirsch HH, Lysandropoulos A, Canales M, Guignard L, Schluep M, Pantaleo G, Du Pasquier RA. Jilek S, et al. Among authors: schluep m. Lancet Neurol. 2010 Mar;9(3):264-72. doi: 10.1016/S1474-4422(10)70006-5. Epub 2010 Jan 29. Lancet Neurol. 2010. PMID: 20117055 Free article.

2

Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis.

Jilek S, Schluep M, Meylan P, Vingerhoets F, Guignard L, Monney A, Kleeberg J, Le Goff G, Pantaleo G, Du Pasquier RA. Jilek S, et al. Among authors: schluep m. Brain. 2008 Jul;131(Pt 7):1712-21. doi: 10.1093/brain/awn108. Epub 2008 Jun 11. Brain. 2008. PMID: 18550621

3

Intrathecal immune responses to EBV in early MS.

Jaquiéry E, Jilek S, Schluep M, Meylan P, Lysandropoulos A, Pantaleo G, Du Pasquier RA. Jaquiéry E, et al. Among authors: schluep m. Eur J Immunol. 2010 Mar;40(3):878-87. doi: 10.1002/eji.200939761. Eur J Immunol. 2010. PMID: 20017197 Free article.

4

Cytokine mRNA profile of Epstein-Barr virus-stimulated highly differentiated T cells in multiple sclerosis: a pilot study.

Jaquiéry E, Jilek S, Schluep M, Le Goff G, Garcia M, Pantaleo G, Du Pasquier RA. Jaquiéry E, et al. Among authors: schluep m. J Neuroimmunol. 2010 Aug 25;225(1-2):167-70. doi: 10.1016/j.jneuroim.2010.04.011. Epub 2010 May 15. J Neuroimmunol. 2010. PMID: 20471696

5

Vitamin D has a direct immunomodulatory effect on CD8+ T cells of patients with early multiple sclerosis and healthy control subjects.

Lysandropoulos AP, Jaquiéry E, Jilek S, Pantaleo G, Schluep M, Du Pasquier RA. Lysandropoulos AP, et al. Among authors: schluep m. J Neuroimmunol. 2011 Apr;233(1-2):240-4. doi: 10.1016/j.jneuroim.2010.11.008. Epub 2010 Dec 24. J Neuroimmunol. 2011. PMID: 21186064

6

MOBP-specific cellular immune responses are weaker than MOG-specific cellular immune responses in patients with multiple sclerosis and healthy subjects.

Jilek S, Schluep M, Pantaleo G, Du Pasquier RA. Jilek S, et al. Among authors: schluep m. Neurol Sci. 2013 Apr;34(4):539-43. doi: 10.1007/s10072-012-1144-4. Epub 2012 Jun 30. Neurol Sci. 2013. PMID: 22752855

7

Impairment of JCV-specific T-cell response by corticotherapy: effect on PML-IRIS management?

Antoniol C, Jilek S, Schluep M, Mercier N, Canales M, Le Goff G, Campiche C, Pantaleo G, Du Pasquier RA. Antoniol C, et al. Among authors: schluep m. Neurology. 2012 Dec 4;79(23):2258-64. doi: 10.1212/WNL.0b013e3182768983. Epub 2012 Nov 21. Neurology. 2012. PMID: 23175722

8

Natalizumab treatment alters the expression of T-cell trafficking marker LFA-1 α-chain (CD11a) in MS patients.

Jilek S, Mathias A, Canales M, Lysandropoulos A, Pantaleo G, Schluep M, Du Pasquier RA. Jilek S, et al. Among authors: schluep m. Mult Scler. 2014 Jun;20(7):837-42. doi: 10.1177/1352458513513208. Epub 2013 Nov 20. Mult Scler. 2014. PMID: 24258149

9

CSF enrichment of highly differentiated CD8+ T cells in early multiple sclerosis.

Jilek S, Schluep M, Rossetti AO, Guignard L, Le Goff G, Pantaleo G, Du Pasquier RA. Jilek S, et al. Among authors: schluep m. Clin Immunol. 2007 Apr;123(1):105-13. doi: 10.1016/j.clim.2006.11.004. Epub 2006 Dec 22. Clin Immunol. 2007. PMID: 17188575

10

Progressive multifocal leukoencephalopathy in two natalizumab-treated stepsisters: An intriguing coincidence.

Bacchetta F, Mathias A, Schluep M, Du Pasquier R. Bacchetta F, et al. Among authors: schluep m. Mult Scler. 2017 Feb;23(2):300-303. doi: 10.1177/1352458516670734. Mult Scler. 2017. PMID: 28165319

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

140 results

Search Page

Filters